MedTech Dive

Olympus expands in cancer tech with $270M buy of BioProtect

Olympus said Tuesday it has agreed to buy Israel-based BioProtect for $270 million to expand its product portfolio in ...

Olympus grows cancer care portfolio with $270 million acquisition

TOKYO- Olympus is expanding its cancer care portfolio with the acquisition of a medtech company based in Israel. Olympus is ...
Medical Device Network on MSN

Olympus agrees $270m BioProtect buyout to expand prostate cancer offerings

BioProtect’s lead product is a spacer system designed to protect healthy tissues during radiation therapies for prostate ...
Globes

Japan’s Olympus buys Israeli co BioProtect for $270m

Japanese medical device company Olympus Corporation announced today it has signed a definitive agreement to acquire Israeli ...

Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced today it has ...
Fierce Biotech

Olympus pushes deeper into oncology with $270M BioProtect deal

Olympus has signed a definitive agreement to acquire BioProtect for $270 million, adding biodegradable balloon spacer ...

Olympus Announces Launch of E-SteriScope™ Single-Use Rhinolaryngoscopes in Canada

Olympus Corporation (Olympus) today announced the Canadian launch of the Vathin E-SteriScope™ single-use flexible video rhinolaryngoscope for use in otorhinolaryngological procedures. The E-SteriScope ...

Eliminating Decision Latency: Haptiq Unites Orion and Olympus to Automate Complex Enterprise Workflows

Haptiq’s integrated platforms bridge the gap between intelligence and action, empowering firms to orchestrate workflows ...
Engadget

Olympus is giving up on cameras

Despite denying persistent rumors that it would exit the camera business, Olympus is doing exactly that. The company has announced that will sell its camera business to Japan Industrial Partners (JIP) ...